[Federal Register Volume 88, Number 164 (Friday, August 25, 2023)]
[Notices]
[Pages 58278-58280]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-18363]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60-Day-23-23HS; Docket No. CDC-2023-0074]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Program Evaluation for PS22-2208 
Component 2. This information collection request is designed to monitor 
and evaluate the PS22-2208 Component 2 funding opportunity's overall 
goal of supporting syringe services program (SSP) subrecipients in 
meeting the needs of people who use drugs (PWUD) and reducing 
infectious disease and other harms related to drug use during the 5-
year PS22-2208 Cooperative Agreement.

DATES: CDC must receive written comments on or before October 24, 2023.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0074 by either of the following methods:

[[Page 58279]]

     Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (www.regulations.gov) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Program Evaluation for PS22-2208 Component 2--New--National Center 
for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for 
Disease Control and Prevention, Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    PS22-2208 Component 2 (Strengthening Syringe Services Programs) 
serves as a coordinated and accountable mechanism for distribution of 
funding to syringe services programs (SSPs) to support implementation 
and expansion of services in areas of the United States, Territories, 
and Tribal Nations disproportionately affected by infectious disease 
consequences of injection drug use. Project activities will directly 
contribute to establishing and expanding a national SSP infrastructure 
and prevention of infectious disease consequences of drug use. CDC has 
funded the National Alliance of State and Territorial AIDs Directors 
(NASTAD) to implement this project. NASTAD, in partnership with 
University of Washington will collect monitoring and evaluation data 
from funded SSPs through their internal mechanisms, both for their 
internal evaluation as well as to report semi-annual and annual project 
performance reports and stratified aggregate data to CDC.
    The primary purpose of this information collection is to monitor 
and evaluate the PS22-2208 Component 2 funding opportunity's overall 
goal of supporting SSP subrecipients in meeting the needs of people who 
use drugs (PWUD) and reducing infectious disease and other harms 
related to drug use. During the first year of this Cooperative 
Agreement, all PS22-2208 SSP subrecipients will be sent a 25-minute 
baseline program evaluation survey at the start of project 
implementation, and a 15-minute quarterly program evaluation survey in 
the following three quarters of the project period. For Years 2-5, new 
PS22-2208 SSP subrecipients will be sent the baseline survey at the 
start of project implementation, and all existing subrecipients will 
receive the quarterly program evaluation survey in the following three 
quarters of the project period. SSP subrecipients will primarily 
complete the survey online in REDCap, with options to complete via 
telephone or videoconferencing modalities. Subrecipients will be asked 
to complete the surveys within one month of receipt and will receive 
weekly reminders until the survey is completed. SSP subrecipients may 
be reminded informally during meetings with NASTAD and may also work 
with their NASTAD point-of-contact to determine an alternate method of 
survey completion. The survey will include questions on operational and 
programmatic characteristics, and quantity of prevention and treatment 
services provided in-person, through tele-health, and through 
navigation to off-site care, during the specified evaluation period.
    Approximately 200 SSPs will participate in the survey. We estimate 
that it will take 70 minutes to complete the baseline survey and three 
quarterly surveys, regardless of how the respondent chooses to complete 
it (i.e., self-administered online or NASTAD staff-administered by 
phone or videoconferencing). CDC requests OMB approval for an estimated 
233 annual burden hours. There is no cost to survey participants other 
than their time.

                                      Estimates of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
          Respondent                  Form           Number of     responses per   per response    Total burden
                                                    respondents     respondent        (hours)       (in hours)
----------------------------------------------------------------------------------------------------------------
All participating SSPs........  Strengthening                200               1           25/60              83
                                 Syringe
                                 Services
                                 Programs
                                 Baseline Survey.
All participating SSPs........  Strengthening                200               3           15/60             150
                                 Syringe
                                 Services
                                 Programs
                                 Quarterly
                                 Survey.
                               ---------------------------------------------------------------------------------

[[Page 58280]]

 
    Total.....................  ................  ..............  ..............  ..............             233
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2023-18363 Filed 8-24-23; 8:45 am]
BILLING CODE 4163-18-P